論文・総説 - 長堀　正和

41. Kento Takenaka, Kazuo Ohtsuka, Yoshio Kitazume, Katsuyoshi Matsuoka, Toshimitsu Fujii, Masakazu Nagahori, Maiko Kimura, Tomoyuki Fujioka, Akihiro Araki, Mamoru Watanabe. Magnetic resonance evaluation for small bowel strictures in Crohn's disease: comparison with balloon enteroscopy. [Epub ahead of print] J. Gastroenterol.. 2016.11; 52 (8): 879-888. ( PubMed, DOI )

42. Kento Takenaka, Kazuo Ohtsuka, Yoshio Kitazume, Masakazu Nagahori, Toshimitsu Fujii, Eiko Saito, Tomoyuki Fujioka, Katsuyoshi Matsuoka, Makoto Naganuma, Mamoru Watanabe. Correlation of the Endoscopic and Magnetic Resonance Scoring Systems in the Deep Small Intestine in Crohn's Disease. Inflamm. Bowel Dis.. 2015.05; ( PubMed, DOI )

43. Satoko Ohfuji, Wakaba Fukushima, Kenji Watanabe, Satoshi Sasaki, Hirokazu Yamagami, Masakazu Nagahori, Mamoru Watanabe, Yoshio Hirota, . Pre-illness isoflavone consumption and disease risk of ulcerative colitis: a multicenter case-control study in Japan. PLoS ONE. 2014.10; 9 (10): e110270. ( PubMed, DOI )

44. Kento Takenaka, Kazuo Ohtsuka, Yoshio Kitazume, Masakazu Nagahori, Toshimitsu Fujii, Eiko Saito, Makoto Naganuma, Akihiro Araki, Mamoru Watanabe. Comparison of magnetic resonance and balloon enteroscopic examination of the small intestine in patients with Crohn's disease. Gastroenterology. 2014.08; 147 (2): 334-342.e3. ( PubMed )

45. Makoto Naganuma, Yasuo Suzuki, Katsuyoshi Matsuoka, Reiko Kunisaki, Naoki Yoshimura, Masakazu Nagahori, Mamoru Watanabe. [Clinical relevance of tacrolimus trough levels in outpatients with active ulcerative colitis]. Nihon Shokakibyo Gakkai Zasshi. 2014.02; 111 (2): 276-287. ( PubMed )

46. Toshimitsu Fujii, Makoto Naganuma, Yoshio Kitazume, Eiko Saito, Masakazu Nagahori, Kazuo Ohtsuka, Mamoru Watanabe. Advancing magnetic resonance imaging in Crohn's disease. Digestion. 2014.01; 89 (1): 24-30. ( PubMed, DOI )

47. Tadakazu Hisamatsu, Fumiaki Ueno, Takayuki Matsumoto, Kiyonori Kobayashi, Kazutaka Koganei, Reiko Kunisaki, Fumihito Hirai, Masakazu Nagahori, Mitsunobu Matsushita, Kenji Kobayashi, Mitsumasa Kishimoto, Mitsuhiro Takeno, Masanori Tanaka, Nagamu Inoue, Toshifumi Hibi. The 2nd edition of consensus statements for the diagnosis and management of intestinal Behçet's disease: indication of anti-TNFα monoclonal antibodies. J. Gastroenterol.. 2014.01; 49 (1): 156-162. ( PubMed, DOI )

48. Eiko Saito, Masakazu Nagahori, Toshimitsu Fujii, Kazuo Ohtsuka, Mamoru Watanabe. Efficacy of salvage therapy and its effect on operative outcomes in patients with ulcerative colitis. Digestion. 2014.01; 89 (1): 55-60. ( PubMed, DOI )

49. Masakazu Nagahori, Toshimitsu Fujii, Eiko Saito, Kazuo Ohtsuka, Mamoru Watanabe. Biologics treatment for ulcerative colitis. Nihon Shokakibyo Gakkai Zasshi. 2013.11; 110 (11): 1909-1915. ( PubMed )

50. Makoto Naganuma, Toshimitsu Fujii, Reiko Kunisaki, Naoki Yoshimura, Masakazu Takazoe, Yoshiaki Takeuchi, Eiko Saito, Masakazu Nagahori, Keiko Asakura, Toru Takebayashi, Mamoru Watanabe. Incidence and characteristics of the 2009 influenza (H1N1) infections in inflammatory bowel disease patients. J Crohns Colitis. 2013.05; 7 (4): 308-313. ( PubMed, DOI )

51. Makoto Naganuma, Masakazu Nagahori, Toshimitsu Fujii, Junko Morio, Eiko Saito, Mamoru Watanabe. Poor recall of prior exposure to varicella zoster, rubella, measles, or mumps in patients with IBD. Inflamm. Bowel Dis.. 2013.02; 19 (2): 418-422. ( PubMed, DOI )

52. Masakazu Nagahori, Sea Bong Hyun, Teruji Totsuka, Ryuichi Okamoto, Erika Kuwahara, Toru Takebayashi, Makoto Naganuma, Mamoru Watanabe. Prevalence of metabolic syndrome is comparable between inflammatory bowel disease patients and the general population. J. Gastroenterol.. 2010.10; 45 (10): 1008-1013. ( PubMed, DOI )

53. 長堀 正和. 【感染症を鑑別したあとは?非感染性腸炎を見極める!】代表的な非感染性腸炎の診療と紹介時の見極めかた　器質的異常に伴う大腸炎　憩室炎,虚血性腸炎ほか 診断と治療. 2024.03; 112 (3): 365-368. ( 医中誌 )

54. 長堀 正和. 治療法の再整理とアップデートのために　専門家による私の治療　直腸粘膜脱症候群 日本医事新報. 2023.08; (5182): 46-47. ( 医中誌 )

55. Matsuoka Katsuyoshi, Yamazaki Hajime, Nagahori Masakazu, Kobayashi Taku, Omori Teppei, Mikami Yohei, Fujii Toshimitsu, Shinzaki Shinichiro, Saruta Masayuki, Matsuura Minoru, Yamamoto Takayuki, Motoya Satoshi, Hibi Toshifumi, Watanabe Mamoru, Fernandez Jovelle, Fukuhara Shunichi, Hisamatsu Tadakazu. Association of ulcerative colitis symptom severity and proctocolectomy with multidimensional patient-reported outcomes: a cross-sectional study JOURNAL OF GASTROENTEROLOGY. 2023.06; ( PubMed, DOI )

56. Takenaka Kento, Kawamoto Ami, Kitazume Yoshio, Fujii Toshimitsu, Udagawa Yumi, Shimizu Hiromichi, Hibiya Shuji, Nagahori Masakazu, Ohtsuka Kazuo, Watanabe Mamoru, Okamoto Ryuichi. Transmural Remission Characterized by High Biologic Concentrations Demonstrates Better Prognosis in Crohn's Disease JOURNAL OF CROHNS & COLITIS. 2023.06; 17 (6): 855-862. ( PubMed, DOI )

57. Vieujean S., Lindsay J. O., Rubin D., D'Amico F., Ahuja V., Silverberg M. S., Sood A., Yamamoto-Furusho J. K., Nagahori M., Watanabe M., Koutroubakis I. E., Foteinogiannopoulou K., Walsh A., Outtier A., Abreu M. T., Dubinsky M., Siegel C., Louis E., Dotan I., Reinisch W., Danese S., Peyrin-Biroulet L.. Analysis of Clinical Trial Screen Failures in IBD: Real World Results from the IOIBD JOURNAL OF CROHNS & COLITIS. 2023.02; 17 794-797.

58. Tsuchiya K., Nagahori M., Hanazawa R., Sasaki M., Sato H., Hirakawa A., Anzai T., Takahashi K., Kobayashi Y., Hibiya S., Takenaka K., Watanabe M.. Serial daily recording of patient-reported outcomes (PRO2) might predict treatment change in the patients with Ulcerative Colitis. JOURNAL OF CROHNS & COLITIS. 2023.02; 17 I316-I317.

59. 渡辺 守, 長堀 正和. 注目の新薬　カログラ錠(カロテグラストメチル) 診断と治療. 2022.12; 110 (12): 1609-1612. ( 医中誌 )

60. 長堀 正和. 【Evidence & Consensusで押さえる　IBDの治療薬　最新版】今後の適切なIBD治療に向けて　難病制度/公費助成制度 薬事. 2022.09; 64 (12): 2527-2529. ( 医中誌 )